搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Pharma Letter
2 分钟
FDA approves first ever oral penem antibiotic in USA for uUTIs
The US Food and Drug Administration (FDA) approved Iterum Therapeutics’ (Nasdaq: ITRM) Orlynvah (sulopenem etzadroxil and ...
devdiscourse
9 小时
Health Sector Sees Highs and Lows Amid Rising Costs and Breakthroughs
Recent health news highlights include high costs of weight-loss drugs like Wegovy, Septerna's strong Nasdaq debut, ...
腾讯网
10 小时
首款!FDA批准创新小分子药物上市
IterumTherapeutics今日宣布,美国FDA已批准其药品Orlynvah(sulopenem etzadroxil & ...
19 小时
Iterum Therapeutics PLC trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
19 小时
Iterum Therapeutics announces FDA approval of Orlynvah
Iterum Therapeutics (ITRM) plc announced that the U.S. Food and Drug Administration has approved Iterum’s new drug application for ...
19 小时
on MSN
Iterum stock rallies 54% on FDA approval of Orlynvah for UTIs
Iterum Therapeutics (NASDAQ:ITRM) stock shot up 54% Friday after the company received FDA approval for its drug Orlynvah for ...
19 小时
Allovir大涨5.06%:背后的商业潜力与市场警示
在2024年10月26日,生物技术公司Allovir, Inc.(股票代码:ALVR.us)盘中股价出现显著波动,迅速拉升5.06%。尽管这一涨幅在整个生物技术行业看来并不算特别突出,但仍引发了广泛的市场关注。本文将深入分析Allovir的股价变动原因,探讨其业务基础、市场前景以及投资者需注意的风险因素,力求为读者呈现一个全面的财经视角。
kalkinemedia
19 小时
Why Did Newell Brands See a Decline in Q3 Sales?
Highlights,Newell Brands reports a decrease in third-quarter net sales for 2024.,The company focuses on a strategic business ...
FiercePharma
19 小时
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
kalkinemedia
19 小时
What Is Iterum Therapeutics' Latest FDA Approval About?
Highlights,Iterum Therapeutics receives FDA approval for its new drug, ORLYNVAH.,ORLYNVAH targets uncomplicated urinary tract ...
19 小时
Allovir, Inc.盘中异动 股价大涨5.06%
北京时间2024年10月26日02时33分,Allovir, Inc.(ALVR.us)股票出现波动,股价快速 拉升 5.06%。截至发稿,该股报0.830美元/股,成交量8.9091万股, 换手率 0.08%,振幅8.10%。
bovnews
20 小时
Rising Against Resistance: Iterum’s (ITRM) New Drug Takes Center Stage
Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈